# A Safety and Pharmacokinetic Study of Proellex®

> **NCT00619385** · PHASE1 · COMPLETED · sponsor: **Repros Therapeutics Inc.** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Proellex

## Key facts

- **NCT ID:** NCT00619385
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619385, "A Safety and Pharmacokinetic Study of Proellex®". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00619385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*